CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

March 2nd, 2011

FDA Finds No Increased Risk For MI With Abacavir

An ongoing safety review by the FDA of the antiviral medication abacavir found no evidence for an increased risk for MI associated with the drug. The FDA said an increased risk for MI with abacavir had been seen in several observational studies and one randomized controlled trial (RCT), but not in other RCTs or in the drug’s safety database. The FDA therefore conducted a meta-analysis of 26 RCTs and found no evidence for an increased risk for MI associated with the drug.

 

Categories: General
Tags: , ,


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.